Fig. 6From: Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberineIn vitro release and in vivo pharmacokinetic studies. a In vitro release profile of the berberine suspension (BBR) and the system (BBR SNE) in PBS (pH = 7.4) (n = 3); b plasma concentration profiles of berberine after oral administration of BBR and BBR SNE in healthy rabbits (n = 6)Back to article page